Apogee Therapeutics, Inc.

NASDAQ: APGE · Healthcare · Biotechnology

PublicHQ Waltham, MA · MiddlesexCIK 0001974640Reports USD

#1 of 1,394 Healthcare companies by revenue

EA Score

——

FH 68DQ —GM —SS 58

v0.1 · 35/100 weight · pillars only

↑ balance-sheet leverage, Altman-Z · ↓ listing tenure, Piotroski F

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$255.8M

Employees

196

Market cap

$8.2B

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Net income-$255.8M-$255.8M2025

Operating income-$285.6M-$285.6M2025

Total assets$937.1M$937.1M2025

Liabilities$33.3M$33.3M2025

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Apogee Therapeutics, Inc. earned -$255.8M in FY2025 net income.

Peers · Healthcare

Hims & Hers Health, Inc.68B TG Therapeutics, Inc.72B AptarGroup, Inc.86A Oscar Health, Inc.50D

Neighbors

Middlesex →

GE Vernova Inc.$38.1B63C Thermo Fisher Scientific Inc.$44.6B86A Analog Devices, Inc.$11.0B87A The TJX Companies, Inc.$60.4B85A Boston Scientific Corporation$20.1B88A Alnylam Pharmaceuticals, Inc.$3.7B79B+

Key facts

CEOMichael Thomas Henderson

SectorHealthcare

IndustryBiotechnology

HeadquartersWaltham, MA

ExchangeNASDAQ: APGE

Employees196

IPO date2023-07-14

Latest filings

8-K2026-06-22 8-K2026-06-22 8-K2026-06-12 8-K2026-05-27 8-K2026-05-27 8-K2026-05-11 10-Q2026-05-11 DEF 14A2026-04-24

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.